Supplementary Fig 1 from Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer

Authors :: Mariana Chavez-MacGregor
Fei Su
Wei He
Karen Rodriguez Lorenc
Tanay S. Samant
Priya Deshpande
Yu Han
Ivan Diaz-Padilla
Becker Hewes
Amy Weise
Luc Dirix
Brigette Ma
Mario Campone
Javier Cortes
Mafalda Oliveira
Shanu Modi
Aditya Bardia
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Fig 1

Tools